Cargando…
Atropine, Ondansetron, and Ketorolac: Supplemental Management of Amniotic Fluid Embolism
Background: Amniotic fluid embolism (AFE) is a rare cause of severe maternal morbidity and mortality. No well-studied protocols are available for management of AFE. We present a case of cardiac arrest secondary to presumed AFE and the use of atropine-ondansetron-ketorolac (AOK). Case Report: A 34-ye...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academic Division of Ochsner Clinic Foundation
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477128/ https://www.ncbi.nlm.nih.gov/pubmed/36189093 http://dx.doi.org/10.31486/toj.21.0107 |